跳至主要内容
临床试验/NCT02877706
NCT02877706招募中不适用

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

University Hospital, Toulouse1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,500
试验地点
1
主要终点
Incidence of Immune thrombocytopenia (ITP) and AIHA

研究概览

简要总结

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients (18+ year-old)
  • newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB
  • Exclusion criteria:
  • - opposition to data collection

排除标准

  • 未提供

结局指标

主要结局

Incidence of Immune thrombocytopenia (ITP) and AIHA

时间窗: Baseline

Number of new cases

Natural evolution and events

时间窗: Baseline and follow-up

Disease duration. Description of bleeding, infection, thrombosis events

次要结局

  • Treatment lines(15 years)
  • Adverse drug reactions(15 years)
  • Complete rate(15 years)
  • Bleeding(15 years)
  • Response(15 years)
  • Rescue treatment(15 years)
  • Events(15 years)
  • Adherence to ITP management guidelines.(15 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验